Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensified Rituximab Prephase Before FCR in CLL
NCT01370772Phase 2Completed
- Sponsor
- French Innovative Leukemia Organisation
- Start
- May 2011
- Primary completion
- Sep 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in chronic lymphocytic leukemia (CLL), sponsored by French Innovative Leukemia Organisation. Started May 2011; status: completed.
02
Drugs
rituximab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01370772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01370772.